Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New carbazole from Kyowa Hakko effective against chemotherapy-induced thrombocytopenia

June 4, 1999

Introgen Therapeutics commences phase I trial of i.v. p53 gene therapy

June 4, 1999

Spotlight on protein farnesyltransferase inhibitors

June 4, 1999

Phase II ECOG trial of didemnin B in melanoma patients yields indeterminate results

June 4, 1999

Rigel identifies cancer- and inflammation-related gene

June 4, 1999

Study indicates potential of KRN-5500 in the treatment of leukemia and lymphoma

June 3, 1999

U. of Alberta designs new bis-benzimidazole anticancer agents

June 3, 1999

Academic investigators describe new agent for BNCT

June 3, 1999

Merck researchers discover nonpeptide GnRH antagonist series

June 3, 1999

Suppression of NF-kappaB enhances antitumor activity of TNF-alpha and CPT-11 via increased apoptosis

June 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...